Selected research
Industry Research
AI-based Clinical Trial Solution Industry Research Report 2026
Market perspective
The global AI-based Clinical Trial Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the AI-based Clinical Trial Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI-based Clinical Trial Solution market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI-based Clinical Trial Solution market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI-based Clinical Trial Solution include AiCure, Antidote, Deep Lens, Saama Technologies, Trials.ai, Deep 6 AI, Innoplexus, Median Technologies and Mendel.ai, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global AI-based Clinical Trial Solution market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI-based Clinical Trial Solution.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
AI-based Clinical Trial Solution Market by Company
AiCure
Antidote
Deep Lens
Saama Technologies
Trials.ai
Deep 6 AI
Innoplexus
Median Technologies
Mendel.ai
Phesi
Tempus
IBM
Digital Reasoning
Insilico Medicine
Insitro
Evotec
PathAI
Cancer Center.ai
AI-based Clinical Trial Solution Segment by Type
Artificial Narrow Intelligence
Artificial General Intelligence
Artificial Super Intelligence
AI-based Clinical Trial Solution Segment by Application
Drug Discovery
Drug Manufacturing
Drug Marketing
Diagnosis and Treatment
Clinical Trials
AI-based Clinical Trial Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-based Clinical Trial Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI-based Clinical Trial Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-based Clinical Trial Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI-based Clinical Trial Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Artificial Narrow Intelligence
- Artificial General Intelligence
- Artificial Super Intelligence
Applications
- Drug Discovery
- Drug Manufacturing
- Drug Marketing
- Diagnosis and Treatment
- Clinical Trials
Companies covered
- AiCure
- Antidote
- Deep Lens
- Saama Technologies
- Trials.ai
- Deep 6 AI
- Innoplexus
- Median Technologies
- Mendel.ai
- Phesi
- Tempus
- IBM
- Digital Reasoning
- Insilico Medicine
- Insitro
- Evotec
- PathAI
- Cancer Center.ai
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 AI-based Clinical Trial Solution by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Artificial Narrow Intelligence
- 2.2.3 Artificial General Intelligence
- 2.2.4 Artificial Super Intelligence
- 2.3 AI-based Clinical Trial Solution by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug Discovery
- 2.3.3 Drug Manufacturing
- 2.3.4 Drug Marketing
- 2.3.5 Diagnosis and Treatment
- 2.3.6 Clinical Trials
- 2.4 Assumptions and Limitations
3 AI-based Clinical Trial Solution Breakdown Data by Type
- 3.1 Global AI-based Clinical Trial Solution Historic Market Size by Type (2021-2026)
- 3.2 Global AI-based Clinical Trial Solution Forecasted Market Size by Type (2027-2032)
4 AI-based Clinical Trial Solution Breakdown Data by Application
- 4.1 Global AI-based Clinical Trial Solution Historic Market Size by Application (2021-2026)
- 4.2 Global AI-based Clinical Trial Solution Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global AI-based Clinical Trial Solution Market Perspective (2021-2032)
- 5.2 Global AI-based Clinical Trial Solution Growth Trends by Region
- 5.2.1 Global AI-based Clinical Trial Solution Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 AI-based Clinical Trial Solution Historic Market Size by Region (2021-2026)
- 5.2.3 AI-based Clinical Trial Solution Forecasted Market Size by Region (2027-2032)
- 5.3 AI-based Clinical Trial Solution Market Dynamics
- 5.3.1 AI-based Clinical Trial Solution Industry Trends
- 5.3.2 AI-based Clinical Trial Solution Market Drivers
- 5.3.3 AI-based Clinical Trial Solution Market Challenges
- 5.3.4 AI-based Clinical Trial Solution Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top AI-based Clinical Trial Solution Players by Revenue
- 6.1.1 Global Top AI-based Clinical Trial Solution Players by Revenue (2021-2026)
- 6.1.2 Global AI-based Clinical Trial Solution Revenue Market Share by Players (2021-2026)
- 6.2 Global AI-based Clinical Trial Solution Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of AI-based Clinical Trial Solution Head Office and Area Served
- 6.4 Global AI-based Clinical Trial Solution Players, Product Type & Application
- 6.5 Global AI-based Clinical Trial Solution Manufacturers Established Date
- 6.6 Global AI-based Clinical Trial Solution Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America AI-based Clinical Trial Solution Market Size (2021-2032)
- 7.2 North America AI-based Clinical Trial Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America AI-based Clinical Trial Solution Market Size by Country (2021-2026)
- 7.4 North America AI-based Clinical Trial Solution Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe AI-based Clinical Trial Solution Market Size (2021-2032)
- 8.2 Europe AI-based Clinical Trial Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe AI-based Clinical Trial Solution Market Size by Country (2021-2026)
- 8.4 Europe AI-based Clinical Trial Solution Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific AI-based Clinical Trial Solution Market Size (2021-2032)
- 9.2 Asia-Pacific AI-based Clinical Trial Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific AI-based Clinical Trial Solution Market Size by Country (2021-2026)
- 9.4 Asia-Pacific AI-based Clinical Trial Solution Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America AI-based Clinical Trial Solution Market Size (2021-2032)
- 10.2 South America AI-based Clinical Trial Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America AI-based Clinical Trial Solution Market Size by Country (2021-2026)
- 10.4 South America AI-based Clinical Trial Solution Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa AI-based Clinical Trial Solution Market Size (2021-2032)
- 11.2 Middle East & Africa AI-based Clinical Trial Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2021-2026)
- 11.4 Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 AiCure
- 12.1.1 AiCure Company Information
- 12.1.2 AiCure Business Overview
- 12.1.3 AiCure Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.1.4 AiCure AI-based Clinical Trial Solution Product Portfolio
- 12.1.5 AiCure Recent Developments
- 12.2 Antidote
- 12.2.1 Antidote Company Information
- 12.2.2 Antidote Business Overview
- 12.2.3 Antidote Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.2.4 Antidote AI-based Clinical Trial Solution Product Portfolio
- 12.2.5 Antidote Recent Developments
- 12.3 Deep Lens
- 12.3.1 Deep Lens Company Information
- 12.3.2 Deep Lens Business Overview
- 12.3.3 Deep Lens Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.3.4 Deep Lens AI-based Clinical Trial Solution Product Portfolio
- 12.3.5 Deep Lens Recent Developments
- 12.4 Saama Technologies
- 12.4.1 Saama Technologies Company Information
- 12.4.2 Saama Technologies Business Overview
- 12.4.3 Saama Technologies Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.4.4 Saama Technologies AI-based Clinical Trial Solution Product Portfolio
- 12.4.5 Saama Technologies Recent Developments
- 12.5 Trials.ai
- 12.5.1 Trials.ai Company Information
- 12.5.2 Trials.ai Business Overview
- 12.5.3 Trials.ai Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.5.4 Trials.ai AI-based Clinical Trial Solution Product Portfolio
- 12.5.5 Trials.ai Recent Developments
- 12.6 Deep 6 AI
- 12.6.1 Deep 6 AI Company Information
- 12.6.2 Deep 6 AI Business Overview
- 12.6.3 Deep 6 AI Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.6.4 Deep 6 AI AI-based Clinical Trial Solution Product Portfolio
- 12.6.5 Deep 6 AI Recent Developments
- 12.7 Innoplexus
- 12.7.1 Innoplexus Company Information
- 12.7.2 Innoplexus Business Overview
- 12.7.3 Innoplexus Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.7.4 Innoplexus AI-based Clinical Trial Solution Product Portfolio
- 12.7.5 Innoplexus Recent Developments
- 12.8 Median Technologies
- 12.8.1 Median Technologies Company Information
- 12.8.2 Median Technologies Business Overview
- 12.8.3 Median Technologies Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.8.4 Median Technologies AI-based Clinical Trial Solution Product Portfolio
- 12.8.5 Median Technologies Recent Developments
- 12.9 Mendel.ai
- 12.9.1 Mendel.ai Company Information
- 12.9.2 Mendel.ai Business Overview
- 12.9.3 Mendel.ai Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.9.4 Mendel.ai AI-based Clinical Trial Solution Product Portfolio
- 12.9.5 Mendel.ai Recent Developments
- 12.10 Phesi
- 12.10.1 Phesi Company Information
- 12.10.2 Phesi Business Overview
- 12.10.3 Phesi Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.10.4 Phesi AI-based Clinical Trial Solution Product Portfolio
- 12.10.5 Phesi Recent Developments
- 12.11 Tempus
- 12.11.1 Tempus Company Information
- 12.11.2 Tempus Business Overview
- 12.11.3 Tempus Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.11.4 Tempus AI-based Clinical Trial Solution Product Portfolio
- 12.11.5 Tempus Recent Developments
- 12.12 IBM
- 12.12.1 IBM Company Information
- 12.12.2 IBM Business Overview
- 12.12.3 IBM Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.12.4 IBM AI-based Clinical Trial Solution Product Portfolio
- 12.12.5 IBM Recent Developments
- 12.13 Digital Reasoning
- 12.13.1 Digital Reasoning Company Information
- 12.13.2 Digital Reasoning Business Overview
- 12.13.3 Digital Reasoning Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.13.4 Digital Reasoning AI-based Clinical Trial Solution Product Portfolio
- 12.13.5 Digital Reasoning Recent Developments
- 12.14 Insilico Medicine
- 12.14.1 Insilico Medicine Company Information
- 12.14.2 Insilico Medicine Business Overview
- 12.14.3 Insilico Medicine Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.14.4 Insilico Medicine AI-based Clinical Trial Solution Product Portfolio
- 12.14.5 Insilico Medicine Recent Developments
- 12.15 Insitro
- 12.15.1 Insitro Company Information
- 12.15.2 Insitro Business Overview
- 12.15.3 Insitro Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.15.4 Insitro AI-based Clinical Trial Solution Product Portfolio
- 12.15.5 Insitro Recent Developments
- 12.16 Evotec
- 12.16.1 Evotec Company Information
- 12.16.2 Evotec Business Overview
- 12.16.3 Evotec Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.16.4 Evotec AI-based Clinical Trial Solution Product Portfolio
- 12.16.5 Evotec Recent Developments
- 12.17 PathAI
- 12.17.1 PathAI Company Information
- 12.17.2 PathAI Business Overview
- 12.17.3 PathAI Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.17.4 PathAI AI-based Clinical Trial Solution Product Portfolio
- 12.17.5 PathAI Recent Developments
- 12.18 Cancer Center.ai
- 12.18.1 Cancer Center.ai Company Information
- 12.18.2 Cancer Center.ai Business Overview
- 12.18.3 Cancer Center.ai Revenue in AI-based Clinical Trial Solution Business (2021-2026)
- 12.18.4 Cancer Center.ai AI-based Clinical Trial Solution Product Portfolio
- 12.18.5 Cancer Center.ai Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst